Newsletter | November 19, 2021

11.19.21 -- Looking For Help With Your Phase I-III Trial?

Considerations For The Clinical Development Of Cell & Gene Therapies

Considerations for the Clinical Development of Cell & Gene Therapies is a 2-part panel discussion with our Precision experts and C-Suite leaders from advanced therapy companies on the front lines of development. Part 1 discusses Cell Therapy development, and Part 2 discusses Gene Therapy development.

Gene Therapy: Creative Solutions For Complex Clinical Development Pathways

We understand how high the stakes are with gene therapy programs. Nothing is standard about the study design, study conduct or regulatory process. Download our presentation from the 4th Annual Gene Therapy for Rare Disorders Meeting to learn about the manufacturing, clinical, and commercialization challenges drug developers face when bringing gene therapies to market.

Clinical Trial Recovery - Rescued Cohorts

A large pharma Sponsor approached QPS to jump into a trial early and complete initial phases of recruitment and enrollment into a large, multi-cohort clinical trial. This case study outlines the challenges faced and the solutions put in place to deliver the study successfully.

New Is Risky. Start With A Free Feasibility Report.

Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.

Localized Attention On A Global Scale: A Phase III Study In Early Alzheimer’s

In a recent Phase III study focusing on mild cognitive impairment (MCI) and mild Alzheimer’s disease, Worldwide Clinical Trials worked with 250 sites across 14 countries in North America, Europe, and the Asia-Pacific region.

UBC Virtual And Decentralized Research Solutions

The UBC decentralized study solution accelerates patient enrollment, enriches the patient’s study experience,  allows you to acquire patient medical records without the need for investigator intervention and capture ‘any data’ from ‘anywhere’ at ‘anytime’ through sophisticated technology and real-world infrastructure.

Parexel FSP

We provide you with a dedicated client partner, a single point of contact, who will help you to access everything Parexel® FSP has to offer.

End-To-End Oncology Development

Pioneers developing the latest targeted therapies turn here for innovation and expertise. We’ve conducted over 170 trials across numerous indications in the past five years.